Acutely exaggerated hepatitis B induced by the withdrawal of immunosuppressants in a seroconverted renal transplant recipient: Report of a case

Surgery Today

Volumn 32, Issue 5, 2002, Pages 472-475

  Gunji, Yoshio ^a   Sakamoto, Kaoru ^b   Sato, Shinichi ^b   Hamaguchi, Kinichi ^b   Kamura, Kouichi ^b   Yamada, Kenichi ^b   Arita, Seiji ^b   Kashiwabara, Hidehiko ^b   Hori, Seiji ^a   Shimada, Hideaki ^a   Suzuki, Takao ^a   Ochiai, Takenori ^a  

^a CHIBA UNIVERSITY   (Japan)

^b SAKURA NATIONAL HOSPITAL   (Japan)

Author keywords

Hepatitis B virus; Renal transplantation; Seroconversion

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DNA POLYMERASE; HEPATITIS B(E) ANTIBODY; MEMBRANE ANTIGEN; NEOMINOPHAGEN C; PREDNISOLONE; VIRUS ANTIGEN; HEPATITIS B ANTIBODY; HEPATITIS B(E) ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CADAVER DONOR; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; DRUG WITHDRAWAL; ENZYME BLOOD LEVEL; GRAFT REJECTION; HEMODIALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; PREDICTION; RECIPIENT; SEROCONVERSION; SEROLOGY; VIREMIA; VIRUS CARRIER; ACUTE DISEASE; BLOOD; HETEROZYGOTE; IMMUNOLOGY; MIDDLE AGED;

ACUTE DISEASE; CARRIER STATE; CASE REPORT; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HUMAN; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGE; HUMANS; MIDDLE AGED;

EID: 0036015812     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950200079     Document Type: Article

References (21)

1. The clinical and pathologic course of hepatitis B liver disease in renal transplant recipients
2. Renal transplantation is not contraindicated in asympatomatic carriers of hepatitis B surface antigen
3. Hepatitis antigenemia and survival after renal transplantation
4. The impact of renal transplantation on the course of hepatitis B liver disease
5. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies. Report on three cases and review of the literature
6. The evaluation of renal transplant candidates: Clinical practice guidelines
7. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection
8. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment
9. Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region
10. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen
11. 1896-containing strains leading to mild resolving acute hepatitis and seroconversion to hepatitis Be antigen antibodies in an adult
12. Redevelopment of hepatitis B surface antigen after renal transplantation
13. De novo and apparent de novo hepatitis B virus infection after liver transplantation
14. Hepatitis B virus contains a glucocorticoid-responsive element
15. The glucocorticoid receptor recognized a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer
16. Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis
17. Modulation of hepatitis B viral antigen expression by immuno-suppressive drugs in primary hepatocyte culture
18. Hepatitis viruses under immunosuppressive agents
19. Scheduling of revaccination against hepatitis B virus
20. Hepatitis B vaccination of immunosup-pressed heart transplant recipients with the vaccine Hepa Gene 3 containing pre-S1, pre-S2, and S gene products
21. Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation